PharmaLundensis AB is a Pharmaceutical company with office and lab at Medicon Village Science Park in Lund, Sweden. The company was founded 2006 by CEO Dr Staffan Skogvall. The shares are traded on Aktietorget since July 2010. Main focus of interest is the development of new treatments for several important lung diseases.
Licensed physician in 1993. Dissertation in Lung Physiology 1999 at Lund University with “Regulation of Spontaneous Tone in Guinea Pig Trachea”. Founded PharmaLundensis AB in 2006, and has since then served as CEO and Research Director.